Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2000
11/09/2000WO2000042031A3 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
11/09/2000WO2000039087A3 Substituted (aminoiminomethyl or aminomethyl)benzoheteroaryl compounds as factor xa inhibitors
11/09/2000WO2000037094A3 Therapeutic applications of flint polypeptides
11/09/2000WO2000033790A3 Methods and compositions for prevention and treatment of arterial lesions with non-steroidal anti-inflammatory drugs
11/09/2000WO2000032584A3 Nonsteroidal antiinflammatories
11/09/2000WO2000031123A3 Retro-inversion peptides that target gastro-intestinal tract transport receptors and use thereof
11/09/2000WO2000030671A3 Nf-at mediates cardiac hypertrophy, methods and reagents related thereto
11/09/2000WO2000030668A3 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration
11/09/2000WO2000028981A3 Methods for treating, preventing, and reducing the risk of the onset of alzheimer's disease using an hmg coa reductase inhibitor
11/09/2000WO2000027422A3 Methods and compositions for treating or preventing peripheral neuropathies
11/09/2000WO2000023565A3 Novel neuropilin/growth factor binding and uses thereof
11/09/2000WO2000021509A3 Methods of treatment
11/09/2000WO2000019989A3 Use of catechol derivatives as proteinase inhibitors
11/09/2000WO2000015785A3 GENE MODIFICATION IN THE GENE FOR THE DIE Gβ3-SUB-UNIT OF HUMAN G-PROTEIN
11/09/2000WO2000010968A3 Novel aryl sulphonamide amino acid esters and analogues
11/09/2000WO2000004050A3 Neurotrophic growth factor
11/09/2000DE19920936A1 Heterozyklisch substituierte Benzimidazole, deren Herstellung und Anwendung Heterocyclic substituted benzimidazoles, their preparation and application
11/09/2000DE19920352A1 Substituiertes Pyrazolderivat Substituted pyrazole derivative
11/09/2000CA2388658A1 1-amino triazolo[4,3-a]quinazolin-5-ones and or -5-thiones inhibiting phosphodiesterase iv
11/09/2000CA2373021A1 Chlamydia antigens and corresponding dna fragments and uses thereof
11/09/2000CA2372948A1 Method of enhancing insulin action
11/09/2000CA2372947A1 Metabolic intervention with glp-1 to improve the function of ischemic and reperfused tissue
11/09/2000CA2372923A1 Dna encoding snorf36a and snorf36b receptors
11/09/2000CA2372803A1 Variants of traf2 which act as an inhibitor of tnf-alpha (tnf .alpha.) signaling pathway
11/09/2000CA2372493A1 Steroid derivatives
11/09/2000CA2372387A1 Ace-2 inhibiting compounds and methods of use thereof
11/09/2000CA2372223A1 Use of phyllanthus for targeted stimulation of the immune system
11/09/2000CA2372220A1 Use of phyllanthus for treating chronically inflammatory and fibrotic processes
11/09/2000CA2372077A1 A method for the prevention of ischemic spinal cord injury caused by aortic crossclamping
11/09/2000CA2371757A1 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents
11/09/2000CA2371671A1 Pyrimidinone compounds
11/09/2000CA2371604A1 Integrin receptor antagonists
11/09/2000CA2371391A1 Pentoxifylline, pioglitazone and metformin are inhibitors of formation of advanced glycation endproducts (age's)
11/09/2000CA2371284A1 6-¬¬(aryl and heteroaryl)oxy| methyl|naphthalene-2-carboximidamide derivatives, preparation and therapeutic application thereof
11/09/2000CA2371271A1 9h-pyrimido¬4,5-b|indole derivatives: crf1 specific ligands
11/09/2000CA2371231A1 Pharmaceutical composition in unit form containing acetylsalicylic acid and clopidogrel hydrogenosulphate
11/09/2000CA2370587A1 Use of heparin-binding antagonists in the inhibition of bradykinin release
11/09/2000CA2369526A1 Use of compounds with a nitrogen-oxygen heterocycle as anti-infectious agents
11/09/2000CA2368748A1 X-ray guided drug delivery
11/09/2000CA2338799A1 Protein c derivatives
11/09/2000CA2336296A1 Novel peptide y-2
11/08/2000EP1050534A1 2,3-methano-amino acid derivatives, process for their preparation and pharmaceutical compositions containing them
11/08/2000EP1049776A1 Phagocytosis genes and uses thereof
11/08/2000EP1049721A1 Synthetic polysaccharides, their method of production and pharmaceutical compositions containing same
11/08/2000EP1049700A1 Chemokine receptor antagonists and methods of use therefor
11/08/2000EP1049699A1 Azolo triazines and pyrimidines
11/08/2000EP1049695A1 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
11/08/2000EP1049693A1 1,3,4-THIADIAZOLES AND 1,3,4-OXADIAZOLES AS $g(a) v?$g(b) 3? ANTAGONISTS
11/08/2000EP1049691A1 Substituted 5-(2,2-difluoro-1,3-benzodioxol-5-yl) cyclopentenopyridine derivative
11/08/2000EP1049689A1 4-(2-keto-1-benzimidazolinyl)piperidine compounds as orl1-receptor agonists
11/08/2000EP1049677A1 Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion
11/08/2000EP1049676A1 4- aryl(piperidin-4-yl)] aminobenzamides which bind to the delta-opioid receptor
11/08/2000EP1049486A1 Glp-1 formulations
11/08/2000EP1049467A1 Celecoxib compositions
11/08/2000EP1049462A1 Choline esters of fatty acids and their use in the treatment of stroke
11/08/2000EP1049441A2 Pharmaceutical compositions comprising thiram for inhibiting angiogenesis
11/08/2000EP0862550B1 Carboxylic acid derivatives, their preparation and their use
11/08/2000EP0787000B1 Quinazolinone pharmaceuticals and use thereof
11/08/2000EP0637307B1 Imidazole, triazole and tetrazole derivatives
11/08/2000CN1272886A Polynucleotide encoding polypeptide having heparanase activity and expression of same in transduced cells
11/08/2000CN1272841A Novel lactam metalloprotease inhibitors
11/08/2000CN1272840A Novel vitamin D derivatives with cyclopropyl rings in lateral chains, its production method and intermediate and utilization thereof for producing medicaments
11/08/2000CN1272786A Endothelin antagonist and beta receptor blocking agent as combined preparation
11/08/2000CN1272493A Novel amino-triazole compound, its preparation method and drug composition containing them
11/08/2000CN1272379A Medicine for curing coronary heart disease, arteriosclerosis and hypertension
11/08/2000CN1272371A Chinese patent medicine 'Jiangyazhi' for curing hypertension
11/08/2000CN1272363A Preparation method of medicine for resisting ischemic cerebrum and brain trauma using taurine
11/08/2000CN1058262C Novel 1-phenylalkanone 5-HT4 receptor ligands
11/08/2000CN1058174C Medicine for curing coronary heart disease and production method thereof
11/08/2000CN1058158C Drug composition for curing heart and brain vascular diseases
11/07/2000US6143894 Preparation of [1S-[1A,2B,3B,4A(S*)]]-4-[7-[[1-(3-chloro-2-thienyl)methyl propyl]amino] -3H-imidazo[4,5-B]pyridin-3-yl]-N-ethyl-2,3-dihydroxycyclopentanecarboxa mide
11/07/2000US6143886 Azepinone compounds useful in the inhibition of ACE and NEP
11/07/2000US6143777 Aminothiophene carboxylic acid amides and the use thereof as phosphodiesterase inhibitors
11/07/2000US6143775 Physical form of zafirlukast; asthma
11/07/2000US6143774 Imidazole n-benzyldioxol derivatives, method for preparing same, resulting intermediates, pharmaceutical compositions and use of said derivatives as endothelin antagonists
11/07/2000US6143749 Heterocyclic substituted cyclopentane compounds
11/07/2000US6143746 Tetracyclic cyclic GMP-specific phosphodiesterase inhibitors, process of preparation and use
11/07/2000US6143743 Treatment of nervous system disorders
11/07/2000US6143741 Treating or preventing illnesses resulting from damaged endothelial cells such as atherosclerosis, thrombosis, restenosis, vessel spasm by administering hydroxylamine derivative
11/07/2000US6143730 As anti-angiogenic, anti-metastatic and/or anti-inflammatory agents
11/07/2000US6143725 For treating vascular diseases
11/07/2000US6143521 Human bombesin receptor subtype-3sb
11/07/2000CA2170485C Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine
11/07/2000CA2166981C Oncoprotein protein kinase
11/07/2000CA2118102C New derivatives of 1,2,3,4-tetrahydronaphthalene, preparation process thereof and pharmaceutical compositions containing the same
11/07/2000CA2080223C Thiophene sulfonamides useful as carbonic anhydrase inhibitors
11/07/2000CA1341136C Arylalkyl-amines and -amides having anticonvulsant and neuroprotective properties
11/06/2000CA2271190A1 Improved method for treating mammals with modified mammalian blood
11/02/2000WO2000066152A1 A pharmaceutical formulation containing an inhibitor of carboxypeptidase u and a thrombin inhibitor
11/02/2000WO2000065075A1 Use of coxsackie viruses for improving cell transfection
11/02/2000WO2000065054A2 Human membrane-associated proteins
11/02/2000WO2000065043A1 Use of a recombinant defective adenovirus comprising a nucleic acid encoding an angiogenic factor for treating pulmonary hypertension
11/02/2000WO2000065028A2 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR
11/02/2000WO2000064946A2 Compositions and methods for cancer treatment by selectively inhibiting vegf
11/02/2000WO2000064944A1 Treatment of fibrosis by antagonism of il-13 and il-13 receptor chains
11/02/2000WO2000064921A2 Process of purifying phytosterols from wood or plant-derived sources by means of metal salt complexes and compositions resulting therefrom
11/02/2000WO2000064911A1 Ligands for metabotropic glutamate receptors
11/02/2000WO2000064899A1 Tetracyclic azepinoindole compounds as 5-ht receptor ligands
11/02/2000WO2000064894A1 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof
11/02/2000WO2000064892A2 Thiazolidinedione derivative and its use as antidiabetic
1 ... 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 ... 1595